• We care
  • Ask our clients
  • After every detail
  • We care
  • The intelligent way
  • New vision of the legal profession
  • Ahead of time
  • Understanding the law
  • The clever solution
Practice Area
Pharma Regulatory
Abbott Laboratories, Amgen (Europe) GmbH, Amgen Limited, Array BioPharma Inc., Aventis Pharma International S.A., B. Braun, Bank of America, Bayer AG, Bio Generix AG, BIOTRONIK GmbH & Co. KG, Boston Scientific Corporation, CSL Behring Beteiligungs- und Verwaltungs GmbH & Co KG, Deutsche Bank, EBRD, Fournier Pharma Inc., GE Medical Systems Information Technologies GmbH, Genesis Pharma S. A., Genzyme Corporation, Genzyme Europe BV, GlaxoSmithKline, GlaxoSmithKline EOOD, H. Lundbeck A/S, I.N.C. Agency B.V., ICN Pharmaceuticals, King Pharmaceuticals, LEK farmacevtska družba d.d., Les Laboratoires Servier, Merz Pharmaceuticals GmbH, Mundipharma, Novartis AG, Pfizer, Protein Design Labs, S.C. Johnson & Son, Inc., Sanofi Aventis, Schering Plough, Solvay, SSL Magyarorszag Kft, Standard Bank Plc, Texas Pacific Group, Tukanna Banka Osteocenter Bulgaria EAD, Vector Tobacco, Zentiva International a.s., ZymoGenetics, Inc.
Client: Texas Pacific Group
Texas Pacific Group on the regulatory regime of Transfusion Therapies Products in the context of the acquisition of the medical devices business of Baxter International Inc.
 
Copyright © 2006 Djingov, Gouginski, Kyutchukov & Velichkov Created by DGKV